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Is the use of topical vancomycin to prevent medias-
tinitis after cardiac surgery justified?
To the Editor:
Patients undergoing cardiopulmonary bypass (CPB) are at
substantial risk of acquiring infections because of the
increased number of potential ports of entry of pathogens in
the presence of CPB-induced impairment of immune
responses.1 Despite regular use of prophylactic intravenous
antibiotics, postoperative mediastinitis occurs in 0.4% to 5%
of patients undergoing cardiac operations.1 This complication
is associated with a 14% to 47% risk of in-hospital mortality.1
Gram-positive bacteria are the most common isolates from
patients with mediastinitis; Staphylococcus aureus and
Staphylococcus epidermidis are identified in 70% to 80% of
cases.1 In a prospective randomized controlled study, Vander
Salm and associates2 found that topical vancomycin applied
during wound closure after median sternotomy was associat-
ed with a significant reduction in the rate of sternal wound
infection. Although this study has not been repeated, its find-
ings were accepted by a number of cardiac surgeons who
have adopted the routine use of topical vancomycin powder
to prevent mediastinitis after CPB (unpublished data).
The risk of vancomycin resistance has been a concern of
those who have adopted this approach. However, 2 factors
have supported the use of vancomycin for this purpose. First,
the drug is instilled in a confined space, which prevents free
movements of organisms in and out of the area at risk. Second,
topical application of vancomycin was believed to result in
insignificant serum levels. We have studied the pharmacoki-
netics of vancomycin powder instilled between the edges of
the sternum during closure of the median sternotomy in 4
patients undergoing CPB. Contrary to the common belief that
topical vancomycin powder is poorly absorbed, levels up to
4.4 mg/L were found in the patients’ serum within 3 to 4 hours
after topical application of 1 g of vancomycin powder (Fig 1).
Recent emergence of vancomycin resistance in methicillin-
resistant S aureus3-5 could raise doubts regarding the wisdom
of continuing this approach. The first report of vancomycin
resistance in methicillin-resistant S aureus occurred after a
cardiac operation in a 4-month-old boy.3 More recently,
Smith and colleagues4 have identified 2 more cases of S
aureus with intermediate resistance to vancomycin. The
mechanism of resistance, however, is not due to the acquisi-
tion of the feared vanA or vanB resistance genes that have
been isolated from vancomycin-resistant enterococci.5 S
aureus–intermediate resistance to vancomycin is believed to
be mediated by accumulation of cell wall components, with
possible alternative vancomycin-binding pathways that divert
vancomycin from its target site.
We wish to debate this issue among the cardiothoracic sur-
geons and the experts in the field of antibiotic resistance.
Such a debate will undoubtedly help to determine the risks
versus the benefits of using topical vancomycin to prevent
mediastinitis after median sternotomy.
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Fig 1. Vancomycin levels before and after instillation of 1 g
of vancomycin powder between the sternal edges during
wound closure. Vancomycin serum levels were measured
before the operation and 1, 3, 6, 24, and 48 hours after instil-
lation of vancomycin. The solid line represents the mean
value of vancomycin levels in milligrams per liter obtained
from 4 patients. The mean values are 0.1, 2.1, 2.2, 1.4, 1.2,
and 0.8 mg/L, respectively.
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In vivo estimation of septal lung tissue volume and
correlation with diffusing capacity in lung volume
reduction surgery
To the Editor
We read with great interest the recent paper by J. C. Chen
and associates1 about the diffusing capacity limitations of the
extent of lung volume reduction surgery (LVRS) in animal
models of emphysema. The authors induced diffuse emphy-
sema by aerosol elastase, a model similar to the homogenous
type of human emphysema. However, patients with emphyse-
ma who are good candidates for LVRS tend to have hetero-
geneous targeted areas for resection,2 as Cooper has men-
tioned.1 In these patients, improvement in respiratory system
compliance is prominent even after resection of a large vol-
ume of the lung. In contrast, diffusing capacity deteriorated
when the resected volume exceeded a threshold. In the setting
of major lung resection, diffusing capacity may predict the
postoperative morbidity and mortality.3 We believe that the
importance of diffusing capacity in LVRS needs to be empha-
sized. The goal of LVRS should be a balance between
improving mechanical function of the lung and diaphragm
without excessive loss of diffusing capacity or of the pul-
monary vascular bed. We congratulate Chen and associates
for raising this important issue.
In Dallas, we4,5 have performed extensive studies to deter-
mine the diffusion limitation after major lung resection at rest
and during exercise. Here, we would like to introduce a method
of assessing the diffusing capacity and septal lung tissue vol-
ume in vivo using combined radiologic and physiologic tech-
niques. We believe this approach has potentially important
applications in LVRS. With the use of an acetylene and a car-
bon monoxide rebreathing method, lung air volume, tissue vol-
ume, diffusing capacity, and cardiac output can be simultane-
ously and noninvasively measured.4 In addition, tissue volume
and air volume were also separately estimated by computed
tomographic (CT) scan, from which topologic distribution of
tissue and air volumes are obtained.6 We compared tissue vol-
ume measured by these 2 techniques in immature dogs at dif-
ferent ages. Half the dogs had undergone resection of the right
lung; the other half had undergone thoracotomy without lung
resection. We6 found significant correlations (P < .01) between
tissue volume measured by CT and rebreathing and between
tissue volume and diffusing capacity in both groups (Fig 1, A
and B). These data suggest that tissue volume is an anatomic
correlate of gas exchange capacity.
The article by Chen and associates reinforces the point that
the key functional parameter of gas exchange is not total lung
volume, but diffusing capacity and tissue volume. Measure-
ment of diffusing capacity and tissue volume may aid the
functional evaluation of patients with emphysema, although
their predictive value in the setting of LVRS requires further
investigation. For example, preoperative measurement of dif-
fusing capacity and tissue volume by the rebreathing method
could identify patients with insufficient gas exchange
reserves who would not benefit from LVRS regardless of
improvements in mechanical lung and respiratory muscle
function. In addition, one could potentially use CT scan to
map out the topologic distribution of tissue volume and to tar-
get regions with a low tissue volume (high air/tissue volume
ratio) for resection.
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Fig 1. Measurement of tissue volume and diffusing capacity by computed tomography and rebreathing. Vt, Tissue
volume; RB, rebreathing; CT, computed tomography; DLCO, diffusing capacity of carbon monoxide.
